World's Best Scientists 2026 revealed!
Kari G. Rabe

Kari G. Rabe

Kari G. Rabe publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kari G. Rabe sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Kari G. Rabe D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kari G. Rabe sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Kari G. Rabe is affiliated with the Mayo Clinic in the United States and has contributed extensively to medical research with a focus on genetics, oncology, and hematology. Their research activities span multiple domains within medicine and molecular biology, encompassing studies that intersect genetics, pathology, oncology, and immunology.

The main fields of study for Rabe include Medicine and Biochemistry, Genetics, and Molecular Biology. Within these, their research has concentrated on specific subfields such as Genetics, Pathology and Forensic Medicine, Oncology, Molecular Biology, and Immunology. This multidisciplinary approach informs their interest in varied clinical and molecular aspects of disease.

Rabe's principal topics of work highlight significant involvement in:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Sarcoma Diagnosis and Treatment
  • Advanced Breast Cancer Therapies

Among the frequent co-authors collaborating with Rabe are Sameer A. Parikh, Neil E. Kay, Susan L. Slager, Timothy G. Call, and Esteban Braggio. These partnerships reflect interdisciplinary teamwork primarily in hematologic malignancies and cancer research.

Rabe commonly publishes in venues known for hematology and oncology scholarship. The notable journals where they have multiple publications include:

  • Blood
  • Cancer Research
  • Blood Cancer Journal
  • Journal of Clinical Oncology
  • Leukemia

Recent significant publications authored by Kari G. Rabe comprise:

  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma, 2020, JAMA Oncology
  • Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017, 2022, Cancer
  • International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia, 2020, Blood
  • Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries, 2022, Nature Genetics
  • Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival, 2021, Nature Communications

Best Publications

  • Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

    Lisa Mirabello;Rebecca J. Troisi;Rebecca J. Troisi;Sharon A. Savage

  • Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

    Thorvardur R. Halfdanarson;K. G. Rabe;J. Rubin;G. M. Petersen

  • International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

    Lisa Mirabello;Rebecca J. Troisi;Rebecca J. Troisi;Sharon A. Savage

  • Lower Cancer Incidence in Amsterdam-I Criteria Families Without Mismatch Repair Deficiency: Familial Colorectal Cancer Type X

    Noralane M. Lindor;Kari Rabe;Gloria M. Petersen;Robert Haile

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study

    Suresh T. Chari;Cynthia L. Leibson;Kari G. Rabe;Jeanine Ransom

  • A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma.

    Maria Teresa Landi;Nilanjan Chatterjee;Kai Yu;Lynn R. Goldin

  • Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

    Suresh T. Chari;Cynthia L. Leibson;Kari G. Rabe;Lawrence J. Timmons

  • The association of telomere length and cancer: a meta-analysis.

    Ingrid M. Wentzensen;Lisa Mirabello;Ruth M. Pfeiffer;Sharon A. Savage

  • Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.

    D. Matthew Gianferante;Lisa Mirabello;Sharon A. Savage

  • The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer

    Fergus J. Couch;Michele R. Johnson;Kari G. Rabe;Kieran Brune

  • Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

    Natali Pflug;Jasmin Bahlo;Tait D. Shanafelt;Barbara F. Eichhorst

  • MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps

    Liang Wang;Linnea M. Baudhuin;Lisa A. Boardman;Kelle J. Steenblock

  • Using Epidemiology and Genomics to Understand Osteosarcoma Etiology

    Sharon A. Savage;Lisa Mirabello

  • BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: A PACGENE study

    David B. Zhen;Kari G. Rabe;Steven Gallinger;Sapna Syngal

  • The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.

    Lisa Mirabello;Wen Yi Huang;Jason Y.Y. Wong;Nilanjan Chatterjee

  • Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.

    Sameer A. Parikh;Kari G. Rabe;Timothy G. Call;Clive S. Zent

  • Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

    Sonja I. Berndt;Christine F. Skibola;Christine F. Skibola;Vijai Joseph;Nicola J. Camp

  • Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

    Alessandra Ferrajoli;Tait D. Shanafelt;Cristina Ivan;Masayoshi Shimizu

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Susan L. Slager
Susan L. Slager Mayo Clinic
Neil E. Kay
Neil E. Kay Mayo Clinic
Tait D. Shanafelt
Tait D. Shanafelt Stanford University
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
James R. Cerhan
James R. Cerhan Mayo Clinic
Celine M. Vachon
Celine M. Vachon Mayo Clinic
Alison P. Klein
Alison P. Klein Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If studying Medicine in the USA isn't your only option, various online healthcare degrees offer flexible career pathways. Prospective students may consider nursing schools with high acceptance rates, which provide more accessible routes into the healthcare workforce.

For those interested in non-clinical roles, exploring medical billing and coding schools that accept fafsa can lead to fast-growing jobs with the possibility of financial aid support.

Nursing programs remain a popular choice. Some aspiring nurses may benefit from absn programs that don't require teas, which can save time and bypass extra standardized testing.

Meanwhile, those seeking management or leadership roles in healthcare should consider an accelerated healthcare administration degree online. This option allows you to complete your studies quickly and start your career in healthcare administration sooner.

Best Scientists Citing Kari G. Rabe

Trending Scientists

Recently Published Articles